Literature DB >> 24297384

Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study.

Pierluigi Macchioni1, Luigi Boiardi, Mariagrazia Catanoso, Giulia Pazzola, Carlo Salvarani.   

Abstract

OBJECTIVE: To compare the performance of published classification/diagnostic criteria for polymyalgia rheumatica (PMR), including the new 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) criteria, in a single-centre study.
METHODS: We studied all consecutive patients with new-onset PMR seen in our centre over 6 years, whose diagnosis was confirmed during a prospective 12-month follow-up period. Subjects were classified by each of the seven different criteria. Sensitivity and specificity were compared. Control population consisted of all consecutive patients aged ≥50 years seen in a 4-year period in our early arthritis clinic who had a 12-month confirmation of a diagnosis of rheumatoid arthritis (RA) or other inflammatory articular diseases.
RESULTS: Data were collected from 136 cases and 149 controls, including 94 patients with RA. The most sensitive criteria were the new 2012 EULAR/ACR classification criteria (92.6%). Adding ultrasound (US) specificity increased from 81.5% to 91.3% in total cases and from 79.7% to 89.9% in RA. Bird criteria had a sensitivity of 89.2% but the lowest specificity (40.2% in total cases and 72.5% in RA). Jones and Nobunaga criteria were the most specific criteria (96.7% and 97.8% in total cases and 98.6% and 99.5% in RA) but the less sensitive (63.1% and 58.2%) ones. Overall, discriminatory ability, as reflected by the area under the receiver operating characteristic curve, was better for the 2012 US EULAR/ACR criteria (0.920 in total cases and 0.910 in RA).
CONCLUSIONS: The new EULAR/ACR criteria in new-onset PMR patients perform best in discriminating PMR from RA and other inflammatory articular diseases. Ultrasound further increases the specificity of the criteria.

Entities:  

Keywords:  bursitis; classification criteria; polymyalgia rheumatica; ultrasonography

Mesh:

Substances:

Year:  2013        PMID: 24297384     DOI: 10.1136/annrheumdis-2013-204167

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  [68/f-Muscle stiffness-like pain for 3 weeks : Preparation for the medical specialist examination: part 34].

Authors:  N Venhoff
Journal:  Internist (Berl)       Date:  2021-04-26       Impact factor: 0.743

Review 2.  Polymyalgia rheumatica: strategies for efficient practice and quality assurance.

Authors:  Michael Schirmer; Christian Dejaco; Bhaskar Dasgupta; Eric L Matteson
Journal:  Rheumatol Int       Date:  2015-06-02       Impact factor: 2.631

3.  [Polymyalgia rheumatica in daily routine practice].

Authors:  M Talke; W A Schmidt
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

Review 4.  [Polymyalgia rheumatica: What is the current status?].

Authors:  M Seitz
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 5.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

6.  Semiquantitative Evaluation of Extrasynovial Soft Tissue Inflammation in the Shoulders of Patients with Polymyalgia Rheumatica and Elderly-Onset Rheumatoid Arthritis by Power Doppler Ultrasound.

Authors:  Takeshi Suzuki; Ryochi Yoshida; Akiko Okamoto; Yu Seri
Journal:  Biomed Res Int       Date:  2017-02-15       Impact factor: 3.411

7.  A Point-Scoring System for the Clinical Diagnosis of Sjögren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland.

Authors:  Jing Chen; Xia Zhao; Haixia Liu; Sheng Zhou; Yunqiang Yang; Shouxin Li; Zhiqun Xianyu; Yunfeng Han; Guifen Shen; Jinming Li; Cong Ye; Wei Sun; Lingli Dong
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

8.  The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population.

Authors:  Max Yates; Karly Graham; Richard Arthur Watts; Alexander James MacGregor
Journal:  BMC Musculoskelet Disord       Date:  2016-07-15       Impact factor: 2.362

9.  Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.

Authors:  Anaïs Huwart; Florent Garrigues; Sandrine Jousse-Joulin; Thierry Marhadour; Dewi Guellec; Divi Cornec; Maelenn Gouillou; Alain Saraux; Valérie Devauchelle-Pensec
Journal:  Arthritis Res Ther       Date:  2018-01-25       Impact factor: 5.156

10.  Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review.

Authors:  Sarah Louise Mackie; Gouri Koduri; Catherine L Hill; Richard J Wakefield; Andrew Hutchings; Clement Loy; Bhaskar Dasgupta; Jeremy C Wyatt
Journal:  RMD Open       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.